XBiotech
XBIT
XBIT
45 hedge funds and large institutions have $17M invested in XBiotech in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 21 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
-1
Holders Change %
-2.17%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
21
Reduced
8
Closed
3
Calls
$132K
Puts
$1.04M
Net Calls
-$910K
Net Calls Change
-$596K
Top Buyers
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
$334K |
| 2 |
Charles Schwab
San Francisco,
California
|
$358K |
| 3 |
Group One Trading
Chicago,
Illinois
|
$214K |
| 4 |
BlackRock
New York
|
$6.43M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$3.54M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
$202K |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
$0 |
| 3 |
Citadel Advisors
Miami,
Florida
|
$0 |
| 4 |
ARTA
A.R.T. Advisors
New York
|
$178K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
$28K |
